Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBloomsbury Regulatory News (BMY)

Share Price Information for Bloomsbury (BMY)

Share Price is delayed by 15 minutes
Get Live Data
621.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 2.00 (0.323%)
Market Cap: £502.04m
BMY Live PriceLast checked at - London Stock Exchange

Intraday Bloomsbury Share Chart

Director/PDMR Shareholding

12 Aug 2025 16:29

RNS Number : 0489V
Bloomsbury Publishing PLC
12 August 2025
 

12 August 2025

 

Bloomsbury Publishing Plc (the "Company")

 

Director/PDMR Shareholdings

 

Sale of shares following the vesting and exercise of options under the Bloomsbury Publishing Plc 2014 Performance Share Plan ("2014 PSP")

 

The Company announced on 11 August 2025 that the conditional share award granted in August 2022 under the 2014 PSP vested at 87% of the maximum on 10 August 2025.

Nigel Newton, Chief Executive and PDMR, acquired 112,472 ordinary shares of 1.25 pence in the Company ("Ordinary Shares") (comprising 103,492 vested 2014 PSP shares and 8,980 dividend equivalent shares, both for nil consideration). Penny Scott-Bayfield, Group Finance Director and PDMR, acquired 70,252 Ordinary Shares (comprising 64,643 vested 2014 PSP shares and 5,609 dividend equivalent shares, both for nil consideration).

On 12 August 2025, Mr Newton and Ms Scott-Bayfield sold 50,867 and 33,185 Ordinary Shares respectively at a share price of £4.764739 per share in order to fund the tax liabilities and administrative fees arising on vesting. Mr Newton and Ms Scott-Bayfield retained the balance of 61,605 and 37,067 Ordinary Shares respectively.

Following these transactions, the shareholdings of Mr Newton and Ms Scott-Bayfield's (including persons closely associated) in the Company are as follows:

PDMR

 

Total shareholding in the Company

Percentage of the Company's issued share capital

Nigel Newton

1,690,596 Ordinary Shares

2.07%

Penny Scott-Bayfield

260,442 Ordinary Shares

0.32%

 

This vesting was satisfied through the transfer of shares from the Bloomsbury Employee Benefit Trust.

 

Notifications

 

The relevant notifications set out below are provided in accordance with the requirements of Article 19 of the EU Market Abuse Regulation.

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Nigel Newton

2

Reason for the notification

a)

Position/status

Chief Executive

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Bloomsbury Publishing PLC

b)

LEI

213800ZL2PEC4C6UOQ53

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 1.25p Each

 

 

ISIN: GB0033147751

b)

Nature of the transaction

Sale of Ordinary Shares to meet tax and administrative fees.

c)

Price(s) and volume(s)

Price

No. of shares

£4.764739

50,867

d)

Aggregated information

- Aggregated volume

- Aggregated price

e)

Date of the transaction

12 August 2025

f)

Place of the transaction

London Stock Exchange

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Penny Scott-Bayfield

2

Reason for the notification

a)

Position/status

Group Finance Director

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Bloomsbury Publishing PLC

b)

LEI

213800ZL2PEC4C6UOQ53

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 1.25p Each

 

 

ISIN: GB0033147751

b)

Nature of the transaction

Sale of Ordinary Shares to meet tax and administrative fees.

c)

Price(s) and volume(s)

Price

No. of shares

£4.764739

33,185

d)

Aggregated information

- Aggregated volume

- Aggregated price

e)

Date of the transaction

12 August 2025

f)

Place of the transaction

London Stock Exchange

 

 

 

For further information, please contact:

Bloomsbury Publishing Plc

Maya Abu-Deeb, Group General Counsel & Company Secretary

maya.abu-deeb@bloomsbury.com

Hudson Sandler

+44 (0) 20 7796 4133

Dan de Belder/ Hattie Dreyfus / Emily Brooker

bloomsbury@hudsonsandler.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBUGDIRDBDGUD
Date   Source Headline
29th Mar 20127:00 amRNSCompletion of sale of Bloomsbury Verlag GmbH
29th Feb 20129:45 amRNSProposed sale of Bloomsbury Verlag GmbH
21st Feb 20128:52 amRNSHolding(s) in Company
14th Feb 20127:00 amRNSNew Business in India
23rd Jan 20124:40 pmRNSHolding(s) in Company
23rd Jan 20124:19 pmRNSHolding(s) in Company
16th Jan 20127:00 amRNSInterim Management Statement
20th Dec 20114:18 pmRNSHolding(s) in Company
9th Dec 201111:52 amRNSDirector/PDMR Shareholding
9th Dec 201111:51 amRNSDirector/PDMR Shareholding
9th Dec 201111:50 amRNSDirector/PDMR Shareholding
6th Dec 20119:04 amRNSDirector/PDMR Shareholding
18th Nov 20114:46 pmRNSBlocklisting Interim Review
10th Nov 20113:21 pmRNSHolding(s) in Company
4th Nov 20111:02 pmRNSHolding(s) in Company
27th Oct 20117:00 amRNSInterim Results
14th Oct 20117:00 amRNSNotice of Results
10th Oct 20117:00 amRNSBloomsbury launches Wisden into India
22nd Aug 20113:38 pmRNSDirector/PDMR Shareholding
22nd Aug 20113:35 pmRNSDirector/PDMR Shareholding
19th Aug 20115:55 pmRNSHolding(s) in Company
17th Aug 20112:26 pmRNSHolding(s) in Company
11th Aug 20111:24 pmRNSResult of AGM
11th Aug 20117:00 amRNSAGM Statement
3rd Aug 20115:11 pmRNSHolding(s) in Company
12th Jul 20113:04 pmRNSAnnual Financial Report
12th Jul 20113:01 pmRNSAnnual Information Update
11th Jul 20117:00 amRNSAcquisition and IMS
23rd Jun 201112:01 pmRNSBloomsbury in eBook partnership with J.K. Rowling
3rd Jun 20115:10 pmRNSHolding(s) in Company
27th May 20117:00 amRNSFinal Results
20th May 20118:42 amRNSBlocklisting Interim Review
6th May 20119:00 amRNSNotice of Results
19th Apr 20118:06 amRNSHolding(s) in Company
8th Apr 201112:22 pmRNSEBT Share Purchase
6th Apr 20115:49 pmRNSEBT Share Purchase
5th Apr 20112:59 pmRNSEBT Share Purchase
1st Apr 20113:23 pmRNSEBT Share Purchase
29th Mar 20114:14 pmRNSEBT Share Purchase
23rd Mar 201111:30 amRNSHolding(s) in Company
21st Mar 20112:56 pmRNSHolding(s) in Company
9th Mar 20114:16 pmRNSDirector/PDMR Shareholding
4th Mar 201110:30 amRNSHolding(s) in Company
28th Feb 20117:00 amRNSInterim Results
25th Feb 20111:00 pmRNSBoard Appointment
21st Jan 20111:09 pmRNSHolding(s) in Company
13th Jan 20117:00 amRNSTrading Statement
7th Jan 20119:38 amRNSHolding(s) in Company
16th Nov 20104:04 pmRNSDirectorate Change
9th Nov 201012:33 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.